Latifah Dosunmu-oparison, APN - Medicare Nurse Practitioner in Marlton, NJ

Latifah Dosunmu-oparison, APN is a medicare enrolled "Nurse Practitioner - Psychiatric/mental Health" in Marlton, New Jersey. Her current practice location is 765 E Route 70, Building A, Marlton, New Jersey. You can reach out to her office (for appointments etc.) via phone at (856) 983-3900.

Latifah Dosunmu-oparison is licensed to practice in New Jersey (license number 26NJ00412600) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1083951677.

Contact Information

Latifah Dosunmu-oparison, APN
765 E Route 70, Building A,
Marlton, NJ 08053-2341
(856) 983-3900
(856) 797-4785



Provider's Profile

Full NameLatifah Dosunmu-oparison
GenderFemale
SpecialityNurse Practitioner - Psychiatric/mental Health
Location765 E Route 70, Marlton, New Jersey
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1083951677
  • Provider Enumeration Date: 01/16/2013
  • Last Update Date: 05/01/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 7517104078
  • Enrollment ID: I20130501000245

Medical Identifiers

Medical identifiers for Latifah Dosunmu-oparison such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1083951677NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LP0808XNurse Practitioner - Psychiatric/mental Health 26NJ00412600 (New Jersey)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Latifah Dosunmu-oparison allows following entities to bill medicare on her behalf.
Entity NameCenter For Family Guidance Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1508803388
PECOS PAC ID: 2860396454
Enrollment ID: O20031125000323

News Archive

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

New focus on long-term effects of Fukushima Daiichi nuclear disaster

The Fukushima Daiichi nuclear disaster spread significant radioactive contamination over more than 3500 square miles of the Japanese mainland in the spring of 2011. Now several recently published studies of Chernobyl, directed by Timothy Mousseau of the University of South Carolina and Anders M-ller of the Universit- Paris-Sud, are bringing a new focus on just how extensive the long-term effects on Japanese wildlife might be.

GeneGo integrates SDM platform with MetaCore and MetaDrug

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, announced today that they have integrated GenomeQuest's Sequence Data Management (SDM) platform with GeneGo's MetaCore and MetaDrug.

Read more Medical News

› Verified 3 days ago

Entity NameGenpsych, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548447881
PECOS PAC ID: 8820172232
Enrollment ID: O20080225000197

News Archive

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

New focus on long-term effects of Fukushima Daiichi nuclear disaster

The Fukushima Daiichi nuclear disaster spread significant radioactive contamination over more than 3500 square miles of the Japanese mainland in the spring of 2011. Now several recently published studies of Chernobyl, directed by Timothy Mousseau of the University of South Carolina and Anders M-ller of the Universit- Paris-Sud, are bringing a new focus on just how extensive the long-term effects on Japanese wildlife might be.

GeneGo integrates SDM platform with MetaCore and MetaDrug

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, announced today that they have integrated GenomeQuest's Sequence Data Management (SDM) platform with GeneGo's MetaCore and MetaDrug.

Read more Medical News

› Verified 3 days ago

Entity NameVioral Health And Behavioral Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598254815
PECOS PAC ID: 4284986167
Enrollment ID: O20181003002201

News Archive

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

New focus on long-term effects of Fukushima Daiichi nuclear disaster

The Fukushima Daiichi nuclear disaster spread significant radioactive contamination over more than 3500 square miles of the Japanese mainland in the spring of 2011. Now several recently published studies of Chernobyl, directed by Timothy Mousseau of the University of South Carolina and Anders M-ller of the Universit- Paris-Sud, are bringing a new focus on just how extensive the long-term effects on Japanese wildlife might be.

GeneGo integrates SDM platform with MetaCore and MetaDrug

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, announced today that they have integrated GenomeQuest's Sequence Data Management (SDM) platform with GeneGo's MetaCore and MetaDrug.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Latifah Dosunmu-oparison is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Latifah Dosunmu-oparison, APN
765 E Route 70, Building A,
Marlton, NJ 08053-2341

Ph: (856) 983-3900
Latifah Dosunmu-oparison, APN
765 E Route 70, Building A,
Marlton, NJ 08053-2341

Ph: (856) 983-3900

News Archive

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

Avisio forms new subsidiary to market its virus detecting nano sensory technology

Avisio, Inc. announced today that it has formed a majority-owned subsidiary to market and commercialize Instant Detect, the company's new nano sensory technology that instantly detects biological viruses. The new company, Diagnostic Nano Applications (DNA), will be headquartered in Riverside, California.

New focus on long-term effects of Fukushima Daiichi nuclear disaster

The Fukushima Daiichi nuclear disaster spread significant radioactive contamination over more than 3500 square miles of the Japanese mainland in the spring of 2011. Now several recently published studies of Chernobyl, directed by Timothy Mousseau of the University of South Carolina and Anders M-ller of the Universit- Paris-Sud, are bringing a new focus on just how extensive the long-term effects on Japanese wildlife might be.

GeneGo integrates SDM platform with MetaCore and MetaDrug

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, announced today that they have integrated GenomeQuest's Sequence Data Management (SDM) platform with GeneGo's MetaCore and MetaDrug.

Read more News

› Verified 3 days ago


Nurse Practitioner Nurses in Marlton, NJ

Jacquelyn Regina Zagone, PMHNP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 777 Route 70 E Ste G101, Marlton, NJ 08053
Phone: 800-413-8020    
Dorothy Westlake,
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 1001 Rt. 73 North, Upper Level A & Main Level, Marlton, NJ 08053
Phone: 856-988-3444    
Phenita Sammantha Mouzon,
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 777 Route 70 E Ste G101, Marlton, NJ 08053
Phone: 856-818-4020    
Mrs. Lisa Spurlock Abrams, APN
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 765 E Route 70, Building A, Marlton, NJ 08053
Phone: 856-797-4721    
Rafia Nicola Grooms, DNP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 765 Route 70 E Bldg A100, Marlton, NJ 08053
Phone: 856-797-4721    Fax: 856-797-4785
Mrs. Yingqiao Chen, PMHNP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 2003 Lincoln Dr W Ste B, Marlton, NJ 08053
Phone: 856-886-8839    Fax: 856-210-1874
Ms. Fleurdeliz Alabanzas Germodo, N.P.
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053
Phone: 856-596-9057    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.